Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission: A decision analysis approach

Annals of Hematology

Volumn 72, Issue 4, 1996, Pages 223-230

  Hertenstein, B ^a   Heil, G ^a   Heimpel, H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute myeloid leukemia; Bone marrow transplantation; Decision analysis; Decision making

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA REMISSION; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; DECISION MAKING; DECISION TREES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029866169     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050164     Document Type: Article

References (47)

1. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903
2. Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D (1994) Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. J Clin Oncol 12:262-267
3. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL (1992) Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelosenous leukemia in first remission. J Clin Oncol 10:41-46
4. Zander AR, Keating M, Dicke K, Dixon D, Pierce S. Jagannath S, Peters L, Horwitz L, Cockerill K, Spitzer G. Vellekoop L, Kantarjian H, Walters R, McCredie K, Freireich EJ (1988) A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 6:1548-1557
5. Appelbaum FR, Fisher LD, Thomas ED (1988) Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 72:179-184
6. Conde E, Iriondo A, Rayon C, Richard C, Fanjtil E, Garijo J, Hermosa V, Coma A, Bello C, Carrera D. et al (1988) Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trial. Br J Haematol 68:219-226
7. Reiffers J, Gaspard MH, Maraninchi D. Michallet M, Marit G, Stoppa AM, Corront B, David B, Gastaut JA, Scotto JJ, et al (1989) Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 72:57-63
8. Willemze R, Fibbe WE, Kluin-Neelemans JC (1991) Bone marrow transplantation or chemotherapy as post remission treatment of adult acute myeloaenous leukemia. Ann Hematol 62:59-63
9. Butturini A, Gale RP (1989) Chemotherapy versus transplantation in acute leukaemia. Br J Haematol 72:1-8
10. International Bone Marrow Transplant Registry (1989) Transplant or chemotherapy in acute myelogenous leukaemia. Lancet 1:1119-1122
11. Hermans J, Suciu S, Stijnen T, Aegerter P, Gorin NC, Gratwohl A, Hayat M, Stryckmans P, Zittoun R, Zwaan FE (1989) Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol 25;545-550
12. Ben-Bassat I, Bandini G, Rosti G, Gale RP (1993) Concise report: are we curing acute myelogenous leukemia? Leuk Res 17:1071-1072
13. Begg CB, McGlave PB, Bennett JM, Cassileth PA, Oken MM (1984) A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia. J Clin Oncol 2:369-378
14. Begg CB, Pilote L, McGlave P (1989) Bone marrow transplantation versus chemotherapy in acute non-lymphocytic leukemia: a meta-analytic review. Eur J Cancer Clin Oncol 25:1519-1523
15. Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP (1992) Therapy decisions in leukemia. Bone Marrow Transplant 9:5-10
16. Berman E, Little C, Gee T, O'Reilly R, Clarkson B (1992) Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. N Engl J Med 326: 156-160
17. Avvisati G, Petti MC, Mandelli F (1993) What is the best treatment for acute promyelocytic leukemia? Leuk Lymphoma 11 [Suppl2]: 29-35
18. Clift RA, Buckner CD, Appelbaum FR (1990) Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 76:1867-1871
19. Mandelli F, Labopin M, Granena A. Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J. Gratwohl A (1994) European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Bone Marrow Transplant 14:293-298
20. Geller RB (1992) Post-remission therapy of acute myelocytic leukemia in adults: curability breeds controversy. Leukemia 6:915-925
21. Ljungman P, De Witte T, Verdonck L, Gahrton G, Freycon F, Gravett P, McCann S, Morgenstern HG, Nikoskelainen J, Powles R, Proctor SJ, Volin L, Zwaan F. Gratwohl A (1993) Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT leukaemia working party prospective analysis from HLA-typing. Br J Haematol 84:61-66
22. Weinstein MC, Fineberg HV (1980) Clinical decision analysis. Saunders, Philadelphia
23. Boyd NF, Sutherland HJ, Heasman KZ, Tritchier DL, Cummings BJ (1990) Whose utilities for decision analysis? Med Decis Making 10:58-67
24. Sanders JE, Buckner CD, Clift RA, Fefer A, McGuffin R, Storb R, Appelbaum F, Bensinger W, Beatty P, Doney K, Durnam D, Martin P, Sullivan K, Stewart P, Witherspoon RP, Thomas ED (1988) Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplant 3:11-19
25. Spinolo JA, Yau JC, Dicke KA, Scott E, Jagannath S, Horwitz LJ, Spitzer G, Zander AR (1992) Second bone marrow transplants for relapsed leukemia. Cancer 69:405-409
26. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermüller J, De Witte T, Holler E. Ansari H (1995) Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041-2050
27. Clift RA, Buckner CD, Appelbaum FR, Schoch G, Petersen FB, Bensinger WI, Sanders J, Sullivan KM, Storb R, Singer J, et al (1992) Allogeneic marrow transplantation during untreated first reiapse of acute myeloid leukemia. J Clin Oncol 10:1723-1729
28. Lau J, Kassirer JP, Pauker SG (1983) Decision maker 3.0: improved decision analysis by personal computer. Med Decis Making 3:39-43
29. Pepe MS, Longton G, Pettinger M, Mon M, Fisher L, Storb R (1992) Summarizing data on survival relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 83:602-607
30. Heil G, Mitrou PS, Hölzer D, Freund M, Link H, Ehninger G, Steinke B, Öhi S, Wandt H, Fakler-Schwalbe E, Schlimok G, Lösch A, Queißer W, Löffler B, Gaus W, Hügel J, Heimpel H. Kurrle E (1995) High-dose cytosine-arabinoside and daunorubicin (HD-ARA-C/DNR) postremission therapy in adults with de novo acute myeloid leukemia (AML): a long-term follow-up of a prospective multicenter trial. Ann Hematol 71:219-225
31. Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W (1990) Post-remission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment. J Clin Oncol 8:1199-1206
32. Zittoun RA, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F. Hayat M, Stryckmans P, Rotoli B, Leoni P. Peetermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217-223
33. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA, Mayer RJ (1994) Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood 111a (abstract)
34. Coiffier B, Philip T, Burnett AK, Symann ML (1994) Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies: Lyon, France, June 4-6. 1993. J Clin Oncol 12:226-231
35. O'Meara JJI, McNutt RA, Evans AT, Moore SW, Downs SM (1994) A decision analysis of streptokinase plus heparin as compared with heparin alone for deep vein thrombosis. N Engl J Med 330:1864-1869
36. Kassirer JP (1994) Incorporating patient's preferences into medical decisions. N Engl J Med 330:1895-1896
37. Ringden O, Horowitz MM, Sondel P, Gale RP, Bigss JC, Champlin RE, Deeg HJ, Dicke K, Masaoka T, Powles RL, et al (1993) Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81:1094-1101
38. Frassoni F, Labopin M, Gorin NC (1994) Evolution of allogeneic BMT in Europe: improved results for patients with acute leukaemia in first remission. Bone Marrow Transplant [Suppl 1]: 186
39. Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Klein JP, Kapoor N, Avalos BR, Cunningham I, Atkinson K, Downs K, Harmon GS.,Daly MB, Brodsky I, Bulova SI. Tutschka PJ (1991) Treatment of acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 78:838-843
40. Biaise D, Maraninchi D, Archimbaud E, Reiffers J, Deveraie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N. et al (1992) Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 79:2578-2582
41. Bunjes D, Hertenstein B, Wiesneth M, Stefanic M, Novotny J, Duncker C, Heit W, Arnold R, Heimpel H (1995) In-vivo/ ex vivo T-cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate. Bone Marrow Transplant 15:563-568
42. Frassoni F, Labopin M, Gluckman E, Prentice HG, Gahrton G, Mandelli F, Carella M, Herve P, Gratwohl A, Goldman J, Corin NC (1994) Are patients with acute leukaemia alive and well 2 years post bone marrow transplantation cured? A European survey. Leukemia 8:924-928
43. Gale RP, Horowitz MM, Bortin MM (1994) IBMTR analysis of results of bone marrow transplantation in acute leukemia. Acute Leukemias, 4. Springer, Berlin Heidelbers New York, pp 683-685
44. Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP (1989) High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: lone-term follow-up and results. J Clin Oncol 7:1260-1267
45. Harousseau JL, Milpied N, Briere J, Desablens B, Leprise PY. Ifrah N, Gandhour B, Casassus P (1991) Double intensive consolidation chemotherapy in adult acute myeloid leukemia. J Clin Oncol 9:1432-1437
46. Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E, et al (1992) Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group. Leukemia 6 [Suppl 2]: 116-119
47. Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R (1992) Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood 80:2977-2982